Q3 2023

Characteristics of non-alcoholic fatty liver disease in Palestinian diabetics: A cross-sectional study

Wassiem Takhman · Mohammad A. Nour · Anas Merai · Lubna Saudi · Mosab Maree · Ahmed Awad ghanem · Jihad Hamaida · Basma Damiri
10.59049/2790-0231.1250 390 المشاهدات 0 الاقتباسات
0
الاقتباسات
390
المشاهدات
الملخص

This cross-sectional study was performed to identify the factors associated with non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients in Nablus, Palestine, and decrease the burden of liver diseases. Patients with T2DM who visited primary healthcare clinics in Nablus from January to April 2022 were invited [n=508] to participate. A face-to-face interview was conducted, and medical reports were used to collect the pa-tient's details. The hepatic steatosis index (HSI) was calculated as an indicator of the possibil-ity of the presence of NAFLD. Ultrasound was used to diagnose fatty liver disease (FLD) as mild, moderate, and severe. 399 Patients completed participation, with a mean age of 56.1±10.4 years; 56.1% were males, 91.2% had an HSI score ≥36, and 8.8% had an HSI score of 30-36. Moreover, 3.8% were diagnosed with mild FLD, 42.1% with moderate FLD, and 3.8% with severe FLD. Compared to patients without fatty liver disease, severe FLD pa-tients were at higher risk of having increased cholesterol levels (OR=1.047), increased HSI (OR=1.32), and diabetic retinopathy (OR=7.074). Predictors for moderate FLD have in-creased cholesterol levels (OR=1.023), glycated hemoglobin (HbA1c) (OR=1.06), HSI (OR=1.21), and age (OR=1.071). Predictors for mild FLD have increased cholesterol levels (OR=1.02), HbA1c (OR=1.312), HSI (OR=1.102), and age (OR=1.047). Decreased levels of low-density lipoproteins were associated with decreased risk of mild (OR=0.982), moderate (OR=0.97), and severe (OR=0.955) FLD. Diabetes treatment regimen, the number of years diagnosed with diabetes, hypertension, high-density lipoprotein, and triglycerides levels were not associated with FLD. In conclusion, the prevalence of NAFLD among Palestinian T2DM patients was higher than the reported global prevalence. Several modifiable (weight, HbA1c, HSI score, total cholesterol, and low-density lipoprotein levels) and non-modifiable (age and diabetic retinopathy) factors were associated with NAFLD. This research recommends a screening program for the early detection of NAFLD among Palestinian people with diabetes using ultrasound.

الاستشهاد بهذا المقال (APA)
Wassiem, T., Mohammad, A. N., Anas, M., Lubna, S., Mosab, M., Ahmed, A. G., Jihad, H., Basma, D. (2023). Characteristics of non-alcoholic fatty liver disease in Palestinian diabetics: A cross-sectional study. Palestinian Medical and Pharmaceutical Journal. https://doi.org/10.59049/2790-0231.1250
أبحاث ذات صلة
A Bibliometric Analysis of Cannabis-Related Research from 2010 To 2022
Chaimae Haboubi; Yahya El Hammoudani; Nidal Jaradat; Shehdeh Jodeh; Khadija Habo · 2024
19
استشهاد
393
An Overview of Nanocapsule and Lipid Nanocapsule: Recent Developments and Future Prospects
Nagib Elmarzugi; Rokaya Amara; Malak Eshmela; Ahmad Eid · 2023
10
استشهاد
392
Health-promoting behaviors among patients with coronary artery disease in Palestine
Ibraheem Al-Aqtam; Muhammad Darawad; Jafar Alshraideh; Manar Nabolsi; Noordeen S · 2023
7
استشهاد
391
5
استشهاد
393
5
استشهاد
392
الوصول
عرض النص الكامل عبر DOI
نُشر في
الرقم الدولي ISSN 2413-8568
الربعية Q3
درجة المؤشر القياس العربي 61
التخصص Medicine & Health Sciences
الناشر An-Najah National University - PMPJ
الدولة 🇵🇸 Palestine
عرض ملف المجلة →
المؤلفون
تفاصيل النشر
السنة 2023
اللغة English
أُضيف في 05 Aug 2026